Clinical trial
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
NCT00478335 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00478335 |
|---|---|
| Title | Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus |
| Official title | Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | University of Aarhus |
| Status | Completed |
| Study type | Interventional |
| Conditions | Nephrogenic Diabetes Insipidus |
| Intervention type | Drug |
| Interventions | sildenafil, calcitonin, hydrochlorothiazide/amiloride, indomethacin, Placebo for sildenafil, placebo for calcitonin |
| Enrollment | 4 |
| Start date | May 1, 2007 |
| Primary completion | Oct 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | May 24, 2007 |
| Last update posted | Feb 12, 2018 |
| Countries | Denmark, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: